南威軟件(603636.SH):與螞蟻集團保持着積極溝通,期待共同探索在個性化健康管理領域的深度合作模式
格隆匯7月28日丨南威軟件(603636.SH)在投資者互動平台表示,茶壽健康屬於廣義的大健康領域,包含AI 醫療健康。公司高度關注螞蟻集團在 AI 醫療領域的創新實踐,茶壽健康聚焦“主動健康”和“個性化生活方式干預”,和螞蟻集團的AI 醫療產品存在顯著的互補性與協同潛力。目前,公司與螞蟻集團保持着積極溝通,期待共同探索在個性化健康管理領域的深度合作模式,包括但不限於技術能力的共享與融合、面向特定用户羣體的精細化健康管理方案設計與運營等方向。未來若有相關進展,公司將嚴格按照有關法律法規的要求及時履行信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.